A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Medtronic PLC stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,040 shares of MDT stock, worth $93,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,040
Previous 1,056 1.52%
Holding current value
$93,506
Previous $92,000 11.96%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$78.71 - $87.02 $1,259 - $1,392
-16 Reduced 1.52%
1,040 $81,000
Q1 2024

Apr 23, 2024

SELL
$82.84 - $88.09 $42,248 - $44,925
-510 Reduced 32.57%
1,056 $92,000
Q4 2023

Feb 01, 2024

SELL
$69.43 - $83.43 $7,637 - $9,177
-110 Reduced 6.56%
1,566 $129,000
Q3 2023

Nov 03, 2023

SELL
$78.22 - $90.4 $31,288 - $36,160
-400 Reduced 19.27%
1,676 $131,000
Q2 2023

Aug 01, 2023

SELL
$79.47 - $91.38 $23,920 - $27,505
-301 Reduced 12.66%
2,076 $182,000
Q1 2023

May 02, 2023

SELL
$76.72 - $87.58 $159,194 - $181,728
-2,075 Reduced 46.61%
2,377 $191,000
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $190,678 - $219,613
-2,503 Reduced 35.99%
4,452 $367,000
Q3 2022

Oct 25, 2022

SELL
$80.75 - $95.31 $43,766 - $51,658
-542 Reduced 7.23%
6,955 $562,000
Q2 2022

Jul 26, 2022

SELL
$87.4 - $113.09 $112,309 - $145,320
-1,285 Reduced 14.63%
7,497 $673,000
Q1 2022

Apr 13, 2022

SELL
$100.58 - $112.38 $195,628 - $218,579
-1,945 Reduced 18.13%
8,782 $974,000
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $22,991 - $29,510
231 Added 2.2%
10,727 $1.11 Million
Q3 2021

Nov 12, 2021

SELL
$122.75 - $135.17 $10,679 - $11,759
-87 Reduced 0.82%
10,496 $1.32 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $733,132 - $815,694
6,203 Added 141.62%
10,583 $1.31 Million
Q1 2021

Apr 14, 2021

BUY
$111.18 - $119.74 $152,316 - $164,043
1,370 Added 45.51%
4,380 $517,000
Q4 2020

Jan 14, 2021

BUY
$100.57 - $117.14 $21,119 - $24,599
210 Added 7.5%
3,010 $353,000
Q2 2020

Jul 30, 2020

SELL
$84.11 - $103.33 $50,466 - $61,998
-600 Reduced 17.65%
2,800 $257,000
Q1 2020

Apr 15, 2020

SELL
$72.92 - $121.3 $156,486 - $260,309
-2,146 Reduced 38.69%
3,400 $307,000
Q4 2019

Jan 22, 2020

SELL
$104.49 - $114.54 $78,889 - $86,477
-755 Reduced 11.98%
5,546 $629,000
Q3 2019

Nov 05, 2019

BUY
$98.02 - $111.18 $175,945 - $199,568
1,795 Added 39.84%
6,301 $684,000
Q2 2019

Aug 09, 2019

BUY
$84.15 - $99.38 $50,490 - $59,628
600 Added 15.36%
4,506 $439,000
Q1 2019

Apr 08, 2019

SELL
$82.45 - $93.79 $595,206 - $677,070
-7,219 Reduced 64.89%
3,906 $356,000
Q4 2018

Feb 13, 2019

BUY
$85.8 - $99.49 $646,932 - $750,154
7,540 Added 210.32%
11,125 $1.01 Million
Q3 2018

Oct 31, 2018

SELL
$85.91 - $99.17 $28,951 - $33,420
-337 Reduced 8.59%
3,585 $353,000
Q2 2018

Aug 07, 2018

SELL
$77.48 - $87.83 $156,742 - $177,680
-2,023 Reduced 34.03%
3,922 $336,000
Q4 2017

Feb 08, 2018

BUY
$76.93 - $83.5 $2,692 - $2,922
35 Added 0.59%
5,945 $480,000
Q2 2017

Aug 07, 2017

BUY
N/A
5,910
5,910 $0

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.